The demand for dermatological drugs in Romania has been on the rise in recent years, driven by several factors that have contributed to the growth of the market.
Customer preferences: One of the key factors driving the growth of the dermatological drugs market in Romania is the increasing awareness of skin health and the importance of proper skincare. Consumers are becoming more conscious of the impact of environmental factors such as pollution and sun exposure on their skin, and are therefore seeking out products that can help protect and improve their skin health.
Trends in the market: The dermatological drugs market in Romania is seeing a trend towards the use of natural and organic products, as consumers become more aware of the potential risks associated with synthetic ingredients. This trend is also being driven by the growing popularity of natural and organic skincare products in other parts of Europe and worldwide.Another trend in the market is the increasing demand for anti-aging products, as the population in Romania continues to age. This has led to the development of new products and treatments that target age-related skin concerns such as wrinkles and age spots.
Local special circumstances: One of the unique features of the dermatological drugs market in Romania is the high prevalence of skin diseases such as psoriasis and atopic dermatitis. This has led to a focus on the development of new treatments for these conditions, and has also contributed to the growth of the overall market.
Underlying macroeconomic factors: The growth of the dermatological drugs market in Romania is also being driven by broader macroeconomic factors such as rising disposable incomes and increasing healthcare spending. As incomes continue to rise in Romania, consumers are becoming more willing to spend money on high-quality skincare products and treatments.Overall, the dermatological drugs market in Romania is expected to continue to grow in the coming years, driven by a combination of changing consumer preferences, new product developments, and broader macroeconomic trends.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
